Back to Quality Research
DOXAmdocs Ltd
Information Technology · EDP Services · Mid
$62.74−1.31%
As of 23 Oct 2026Mkt cap $6.5B
Stage 13
WATCH
Fundamentals
47.7/75
Technical
10.3/15
Independent
57.9/90
GCAE viewtiming is actionable but business strength/confidence is below BUY requirements
Price
- 1M
- +8.5%
- 3M
- +18.2%
- 6M
- −3.9%
- 1Y
- −25.2%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 12.4xHist median 18.6x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- —
- FCF yield
- —
Quality
- ROIC
- 15.1%
- Operating margin
- 13.4%
- FCF margin
- 14.2%
- Current ratio
- 1.2x
Growth
- Revenue growth
- −9.4%Latest FY YoY
- Revenue CAGR
- +1.4%
- EPS CAGR
- −1.3%
- FCF CAGR
- −2.5%
Capital
- Share-count trend
- −3.8%3Y annualised
- Net debt
- $501M0.7x OCF
Annual trend
- CAGR 2021–2025
- +1.4%
- Latest · 2025
- $5B
- YoY
- −9.4%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
timing is actionable but business strength/confidence is below BUY requirements
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- WATCH
- Technical state
- early-recovery
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded